BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29871793)

  • 1. Antimüllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies.
    Lyttle Schumacher BM; Jukic AMZ; Steiner AZ
    Fertil Steril; 2018 Jun; 109(6):1065-1071.e1. PubMed ID: 29871793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages.
    Grande M; Borobio V; Bennasar M; Stergiotou I; Mercadé I; Masoller N; Peñarrubia J; Borrell A
    Fertil Steril; 2015 May; 103(5):1221-7.e2. PubMed ID: 25796318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?
    Stochino-Loi E; Darwish B; Mircea O; Touleimat S; Millochau JC; Abo C; Angioni S; Roman H
    Fertil Steril; 2017 Mar; 107(3):707-713.e3. PubMed ID: 28089574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.
    Zarek SM; Mitchell EM; Sjaarda LA; Mumford SL; Silver RM; Stanford JB; Galai N; Schliep KC; Radin RG; Plowden TC; DeCherney AH; Schisterman EF
    Fertil Steril; 2016 Apr; 105(4):946-952.e2. PubMed ID: 26707905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in maternal serum concentrations of antimüllerian hormone in individual women during conception cycles and early pregnancy.
    Hamilton K; Hadlow N; Roberts P; Sykes P; McClements A; Coombes J; Matson P
    Fertil Steril; 2016 Nov; 106(6):1407-1413.e2. PubMed ID: 27565260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis.
    Busnelli A; Somigliana E; Cirillo F; Levi-Setti PE
    Hum Reprod Update; 2021 Oct; 27(6):973-988. PubMed ID: 34254138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction.
    Kaing A; Jaswa EA; Diamond MP; Legro RS; Cedars MI; Huddleston HG
    Fertil Steril; 2021 Feb; 115(2):438-446. PubMed ID: 32883514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer.
    Tarasconi B; Tadros T; Ayoubi JM; Belloc S; de Ziegler D; Fanchin R
    Fertil Steril; 2017 Sep; 108(3):518-524. PubMed ID: 28865551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.
    Reichman DE; Goldschlag D; Rosenwaks Z
    Fertil Steril; 2014 Apr; 101(4):1012-8.e1. PubMed ID: 24491452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage? A cohort study.
    Atasever M; Soyman Z; Demirel E; Gencdal S; Kelekci S
    Fertil Steril; 2016 May; 105(5):1236-1240. PubMed ID: 26806685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of testosterone and antimüllerian hormone with time to pregnancy and pregnancy loss in fecund women attempting pregnancy.
    Sjaarda LA; Mumford SL; Kuhr DL; Holland TL; Silver RM; Plowden TC; Perkins NJ; Schisterman EF
    Fertil Steril; 2018 Mar; 109(3):540-548.e1. PubMed ID: 29428315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
    Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
    Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis.
    Tal R; Tal O; Seifer BJ; Seifer DB
    Fertil Steril; 2015 Jan; 103(1):119-30.e3. PubMed ID: 25450298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes.
    McCormack CD; Leemaqz SY; Furness DL; Dekker GA; Roberts CT
    J Obstet Gynaecol; 2019 Jul; 39(5):623-627. PubMed ID: 30917731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone as a marker of abortion in the first trimester of spontaneous pregnancy.
    Kostrzewa M; Żyła M; Garnysz K; Kaczmarek B; Szyłło K; Grzesiak M
    Int J Gynaecol Obstet; 2020 Apr; 149(1):66-70. PubMed ID: 31978251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood anti-Müllerian hormone is a possible determinant of recurrent early miscarriage, yet not conclusive in predicting a further miscarriage.
    Leclercq E; de Saint Martin L; Bohec C; Le Martelot MT; Roche S; Alavi Z; Mottier D; Pasquier E
    Reprod Biomed Online; 2019 Aug; 39(2):304-311. PubMed ID: 31186176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in anti-Müllerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndrome.
    Köninger A; Kampmeier A; Schmidt B; Frank M; Strowitzki T; Kimmig R; Gellhaus A; Mach P
    Reprod Biomed Online; 2018 Sep; 37(3):367-374. PubMed ID: 30146442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.